249 related articles for article (PubMed ID: 22142191)
1. Mechanistic insights into LDL nanoparticle-mediated siRNA delivery.
Jin H; Lovell JF; Chen J; Lin Q; Ding L; Ng KK; Pandey RK; Manoharan M; Zhang Z; Zheng G
Bioconjug Chem; 2012 Jan; 23(1):33-41. PubMed ID: 22142191
[TBL] [Abstract][Full Text] [Related]
2. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA.
Kim HR; Kim IK; Bae KH; Lee SH; Lee Y; Park TG
Mol Pharm; 2008; 5(4):622-31. PubMed ID: 18461969
[TBL] [Abstract][Full Text] [Related]
3. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
4. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy.
Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN
Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047
[TBL] [Abstract][Full Text] [Related]
5. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
Wang XL; Xu R; Lu ZR
J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
[TBL] [Abstract][Full Text] [Related]
6. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
7. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
[TBL] [Abstract][Full Text] [Related]
8. Monodispersed brush-like conjugated polyelectrolyte nanoparticles with efficient and visualized siRNA delivery for gene silencing.
Jiang R; Lu X; Yang M; Deng W; Fan Q; Huang W
Biomacromolecules; 2013 Oct; 14(10):3643-52. PubMed ID: 24040909
[TBL] [Abstract][Full Text] [Related]
9. Layer-by-layer nanoparticles as an efficient siRNA delivery vehicle for SPARC silencing.
Tan YF; Mundargi RC; Chen MH; Lessig J; Neu B; Venkatraman SS; Wong TT
Small; 2014 May; 10(9):1790-8. PubMed ID: 24510544
[TBL] [Abstract][Full Text] [Related]
10. Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles.
Wong Y; Markham K; Xu ZP; Chen M; Max Lu GQ; Bartlett PF; Cooper HM
Biomaterials; 2010 Nov; 31(33):8770-9. PubMed ID: 20709387
[TBL] [Abstract][Full Text] [Related]
11. Functional gene silencing mediated by chitosan/siRNA nanocomplexes.
Ji AM; Su D; Che O; Li WS; Sun L; Zhang ZY; Yang B; Xu F
Nanotechnology; 2009 Oct; 20(40):405103. PubMed ID: 19752491
[TBL] [Abstract][Full Text] [Related]
12. Efficient siRNA delivery to mammalian cells using layered double hydroxide nanoparticles.
Ladewig K; Niebert M; Xu ZP; Gray PP; Lu GQ
Biomaterials; 2010 Mar; 31(7):1821-9. PubMed ID: 19922997
[TBL] [Abstract][Full Text] [Related]
13. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.
Benfer M; Kissel T
Eur J Pharm Biopharm; 2012 Feb; 80(2):247-56. PubMed ID: 22085653
[TBL] [Abstract][Full Text] [Related]
14. In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles.
Jin J; Bae KH; Yang H; Lee SJ; Kim H; Kim Y; Joo KM; Seo SW; Park TG; Nam DH
Bioconjug Chem; 2011 Dec; 22(12):2568-72. PubMed ID: 22070554
[TBL] [Abstract][Full Text] [Related]
15. Cationic drug-derived nanoparticles for multifunctional delivery of anticancer siRNA.
Chang RS; Suh MS; Kim S; Shim G; Lee S; Han SS; Lee KE; Jeon H; Choi HG; Choi Y; Kim CW; Oh YK
Biomaterials; 2011 Dec; 32(36):9785-95. PubMed ID: 21937102
[TBL] [Abstract][Full Text] [Related]
16. siRNA delivery into tumor cells by lipid-based nanoparticles composed of hydroxyethylated cholesteryl triamine.
Hattori Y; Nakamura T; Ohno H; Fujii N; Maitani Y
Int J Pharm; 2013 Feb; 443(1-2):221-9. PubMed ID: 23279939
[TBL] [Abstract][Full Text] [Related]
17. Self-assembly cationic nanoparticles based on cholesterol-grafted bioreducible poly(amidoamine) for siRNA delivery.
Chen CJ; Wang JC; Zhao EY; Gao LY; Feng Q; Liu XY; Zhao ZX; Ma XF; Hou WJ; Zhang LR; Lu WL; Zhang Q
Biomaterials; 2013 Jul; 34(21):5303-16. PubMed ID: 23570718
[TBL] [Abstract][Full Text] [Related]
18. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Katas H; Cevher E; Alpar HO
Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
[TBL] [Abstract][Full Text] [Related]
19. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
[TBL] [Abstract][Full Text] [Related]
20. The packaging of siRNA within the mesoporous structure of silica nanoparticles.
Li X; Xie QR; Zhang J; Xia W; Gu H
Biomaterials; 2011 Dec; 32(35):9546-56. PubMed ID: 21906804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
